Cell Therapy Manufacturing & Gene Therapy Congress 2016

Best before... Image: StanleyD

Cell Therapy Manufacturing & Gene Therapy Congress - Brussels, Belgium

Short shelf-life poses problems for cell therapy makers, Chiesi

By Dan Stanton

The shelf life of a cell therapy product is crucial in determining a firm’s manufacturing strategy according to the makers of the first approved stem-cell based drug.

Picture credit/ istock

Cell and gene therapy firms talk manufacturing in Belgium

By Gareth MACDONALD

Intrepid Biopharma-Reporter scribe @danjamesstanton has braved heavy turbulence and travel delays to join cell therapy manufacturing experts in Brussels. Check back for regular updates from the conference.